PubMed ID:
26656320
Public Release Type:
Journal
Publication Year: 2016
Affiliation: Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
DOI:
https://doi.org/10.2215/CJN.02560315
Authors:
Appel GB,
Fervenza FC,
Adler SG,
Avila-Casado C,
Bagnasco SM,
Barisoni-Thomas L,
Brady TM,
Cattran DC,
Choi MJ,
Dell KM,
Fornoni A,
Gadegbeku CA,
Gibson KL,
Gipson DS,
Greenbaum LA,
Hewitt SM,
Hingorani SR,
Hladunewich MA,
Hodgin JB,
Hogan MC,
Hogan SL,
Holzman LB,
Ilori TO,
Jennette JC,
Johnstone DB,
Kaskel FJ,
Kopp JB,
Kretzler M,
Lafayette RA,
Lemley KV,
Licht C,
Lieske JC,
Mariani LH,
Meyers KE,
Mokrzycki MH,
Moxey-Mims MM,
Nachman PH,
Nast CC,
Nelson PJ,
Neu AM,
Palmer MB,
Perumal K,
Reich HN,
Rosenberg AZ,
Sambandam KK,
Sampson MG,
Sedor JR,
Sethna CB,
Song P,
Trachtman H,
Troost JP,
Tuttle KR,
Zhdanova O,
Zilleruelo GE
Studies:
Nephrotic Syndrome Study Network
This analysis from the Nephrotic Syndrome Study Network (NEPTUNE) assessed the phenotypic and pathology characteristics of proteinuric patients undergoing kidney biopsy and defined the frequency and factors associated with complete proteinuria remission (CRever).